Grab Group CEO Anthony Tan Recognized with Top Honor at 41st Singapore Business Awards Trump Reaffirms US Commitment to India Underscoring Potential for Enhanced Economic Ties BP Removes Chair Albert Manifold Over Governance and Conduct Concerns Michael Saylor Foresees Tokenization Disrupting Traditional Banking by Enabling Yield Shopping Palantir and Dell Partner to Develop SecurityFocused AI Operating System Bandus Stock Picking Contest Highlights ShortTerm Market Speculation Teleflex Q1 2026 Earnings EPS Beats Estimates by 14 as Company Maintains Steady Performance Flanigans Enterprises Inc BDL Q3 2025 Earnings Positive EPS Delivers Share Boost Amid Sparse Disclosures OCFC Q1 2026 Earnings EPS Beat Amid Challenging Environment HMY Q2 2016 Earnings Disappointing EPS Miss Sends Shares Lower CHRW Q1 2026 Earnings EPS Beats Estimates Shares Rise 21 Welltower Inc Q1 2026 Earnings Strong EPS Beat Signals Robust Portfolio Performance Apple Hospitality REIT APLE Faces Resistance Stock Slightly Lower on Modest Volume Golar LNG GLNG Holds Steady Near Resistance Trading in Tight Range Lightbridge Corporation LTBR Surges Over 45 Testing Key Resistance Levels Linkage Global Inc LGCB Holds Steady Near Support as Traders Assess MicroCap Dynamics Bluerock Homes Trust BHM Edges Higher Navigating Support and Resistance at 1062 Lululemon Stock Gains After Reaching Deal with Founder Chip Wilson to Resolve Proxy Fight Cactus Inc WHD Q1 2026 Earnings EPS Beat Fails to Boost Sentiment as Shares Slip Sequans Communications SQNS Slides 55 as Selling Pressure Mounts Key Levels in Focus Zentalis Pharmaceuticals ZNTL Rises 152 as Stock Tests Key Resistance Urban Edge Properties UE Posts Modest Gain Holds Near MidRange Support Renatus Tactical Acquisition Corp I Unit RTACU Hovers Near Key Support Amid Quiet Trading Cadiz Inc Depositary Shares CDZIP Edge Lower in Quiet Trading Key Support Holds Near 1947 RILYT Notes Slide 147 as Interest Rate Sensitivity Weighs on Bond Prices Future FinTech Group FTFT Faces Resistance After Modest Decline Moleculin Biotech MBRX Holds Steady at 239 as Trading Remains Flat